Today, on #WorldPancreaticCancerDay, we wear 💜 to support those affected by this disease. Our Pancreatic Cancer Team at @crcm_marseille - @paoli_calmettes is fully committed to advancing research for better diagnosis & treatments, with invaluable support from @laliguecancer.

New review in Translational Oncology!.PDAC is not static but a phenotypic continuum shaped by epigenetics & the microenvironment. @crcm_marseille & Medical College of Wisconsin @precision_ru @mellowescenter collaboration. 📄 #PDAC #Epigenetics

Proud to have contributed to this new work in Science Advances! Congrats to @ShivKSingh6 and team for revealing how TP53 missense mutations fuel plasticity & resistance in PDAC, highlighting the need for combined therapies.🔗

Honored to see our work highlighted. Our review dives into new avenues for personalized treatment in pancreatic cancer. Hope it’s useful for the community! 👇.

Honored to speak at @EurPancClub 🇩🇪 on personalizing pancreatic cancer care & preclinical models. The data and concepts I presented are detailed in our review 👉 Cancer Treatment Reviews Thanks @EurPancClub @Anticancerfund @P_C_E_ !

Inspired after the @EurPancClub meeting in Düsseldorf organized by @IEspositoPATH. A wonderful connection has been made with our colleagues @PancreasVerona to collaborate. #PaCaTeam @crcm_marseille, @paoli_calmettes. European Pancreatology at its best 🇫🇷🇮🇹🇪🇺

I firmly believe that only through global collaboration, innovative research, and continuous knowledge sharing can we make progress against these complex cancers. The presentations were truly inspiring and carry an important message for all young researchers.

Honoured to join experts at the #G7Cancer conference in Paris on June 26, organised by #INCa & NCC Japan. Proud to represent our work at @crcm_marseille & @paoli_calmettes.Replay here 👉

RT @Aiims1742: Yoshi Majima (founder of @PanCAN Japan) has been a passionate advocate for patients & families for over two decades. He talk….

RT @OncoDailyGI: Article on Medical Management of Pancreatic Cancer Just Accepted in Cancer Treatment Reviews - @NelsonDusetti . https://t.….

Research Engineer in Molecular Biology and Spatial Transcriptomics (36-month contract – SCHEMA-PDAC project) | EURAXESS

RT @oncodaily: Excited to announce the kick-off meeting of EU-funded project COMBAT-PDAC - Nelson Dusetti (@NelsonDusetti) .@VHIO @paoli_ca….

It has been a privilege to contribute to the work led by Corinne Bousquet’s team on FKBP7 in #PancreaticCancer. Unveiling FKBP7 as an Early Endoplasmic Reticulum Sentinel in Pancreatic Stellate Cell Activation, Collagen Remodelling and Tumor Progression

On March 20, 2025, at Jeudi du PSCC #15, I’ll present our latest research on personalized chemotherapy in pancreatic cancer, focusing on AI-driven heterogeneity deconvolution and preclinical models.

Honored to be awarded by Canceropôle PACA 2024!.This support our work on chemoresistance & predictive models for pancreatic cancer. Proud to share this with @GarciazSylvain for his “TapeStream” project on AML. Thanks for boosting research at @crcm_marseille & @paoli_calmettes !

Honored to represent the @translateitcrcm departement from @crcm_marseille alongside Joseph Ciccolini at the 11th ABCD, part of JFCD 2025 in Paris. discussing predictive signatures, ADCs, and bispecifics in oncology. Thanks to UCGI-Unicancer!. 🔗

Thrilled to visit IRCCS Ospedale San Raffaele @SanRaffaeleMI. Grateful to G. Capurso @lelecapurso , M. Reni & G. Orsi for the kind invitation. Excited to exchange ideas and explore collaborations with their Pancreas Center and our teams at @paoli_calmettes & @crcm_marseille .

It was a pleasure collaborating with @JaunePonsE C. Pin @clpin007, @RaulUrrutia10 and @GLomberk . Our recent study in @JCI_insight reveals how EZH2 regulates PDAC initiation and progression, opening new therapeutic avenues.

2024 was a year full of exciting adventures and improvements. Here’s to 2025 being even better!.

Grateful to @OncoDailyGI for featuring our work. Your updates on treatments, trials, and early screening are vital for advancing personalized cancer care.

We’re honored that the @crcm_marseille and our team are highlighted in this article on our European project tackling pancreatic cancer. Huge thanks to @Insermpacacorse for showcasing our work and collaborations!. 🔗 Read more: